Inhibrx Biosciences, Inc. INBX
- ozekibart — Chondrosarcoma NDA Submitted
- ozekibart — Ewing Sarcoma Phase 1
- ozekibart — Colorectal Adenocarcinoma Phase 1
- ozekibart — Glioblastoma Preclinical
DR5 (1 companies · 4 programs)
Companies with an active program directed at DR5.